128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture

Let's Combinate · 20 Mar 2024 · 52m

What this episode covers

Vin Cafiso, former FDA Consumer Safety Officer and Managing Consultant at Practical Compliance Results, discusses the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR) and its impact on small medical device companies. He explains how FDA inspection methodologies are shifting from issue-focused 483s to process-based QSET audits, emphasizing the importance of understanding quality culture through simple engagement rather than rigid metrics. Cafiso shares insights from his career at companies like BD and Smith & Nephew, highlighting how starting as an investigator builds a strong foundation for industry roles by providing a broad view of quality systems across diverse products and company sizes.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 48m

    QMSR: The Future of FDA's Quality Management System Regulation for Medical Devices

    Mike Drues of Vascular Sciences and George Zack of Two Harbors Consulting discuss the FDA's proposed Quality Management System Regulation (QMSR) to align 21 CFR Part 820 with ISO 13485:2016. The panel argues that the transition is a small leap for compliant companies, focusing on paperwork rather than engineering changes, and questions the value of constant regulatory updates. They highlight the tension between compliance and actual product quality, noting that while harmonization is a step toward global standards, true global regulatory harmonization remains unlikely due to differing national protections.

  • Global Medical Device Podcast · 33m

    #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls

    Nikhil Mangale, Vice President of Quality at Kapstone Medical, discusses the real-world impact of the FDA's Quality Management System Regulation (QMSR) based on seven months of inspection data. He identifies the top five FDA citations as risk management, supplier controls, complaint handling, Unique Device Identification (UDI), and corrective actions, noting that inspectors now focus on operational processes rather than terminology updates like renaming Design History Files (DHF) to Design and Development Files (DDF). Mangale advises companies to implement a three-layer mapping strategy, prioritize risk management as a living process, and maintain open DDFs throughout the product lifecycle to avoid citations. He also clarifies that ISO 13485 certification does not exempt companies from FDA inspections and highlights the continued value of MDSAP enrollment for sites in multiple jurisdictions.

  • Global Medical Device Podcast · 20m

    Meet a Guru: Sara Adams

    Sara Adams, a medical device guru at Greenlight Guru, discusses her background as a quality engineer and her experience implementing an electronic Quality Management System (QMS) at a previous employer. She explains the challenges of transitioning from a paper-based system, emphasizing the importance of laying a strong foundation through documents and training to manage employee resistance to change. Adams also highlights the industry shift toward virtual audits during the pandemic and stresses the importance of understanding ISO 13485 and FDA requirements for medical device companies.

  • Global Medical Device Podcast · 54m

    #329 The Right Way to Start a QMS: When, How, & What

    Rob MacCuspie, Manager of Regulatory and Quality Affairs at Proxima Clinical Research, explains how to build a Quality Management System (QMS) by balancing investor cost concerns with FDA regulatory requirements. He argues that a QMS is not just a document management system but a culture driven by management responsibility and people, using a 'highway vs. mountain road' analogy to describe risk-based rigor for different device classes. MacCuspie details the phased implementation of QMS components, the specific challenges of Software as a Medical Device (SaMD) regarding labeling and testing, and the operational efficiency gains of moving from paper to compliant electronic systems like Greenlight Guru.

  • Global Medical Device Podcast · 19m

    #438: QMSR Mythbusters Episode

    Host Etia Nichols from Greenlight Guru explains the FDA's new Quality Management System Regulation (QMSR), which replaces 21 CFR Part 820 and incorporates ISO 13485:2016 by reference, with a mandatory enforcement date of February 2, 2026. Nichols debunks the myth that the Device Master Record (DMR), Design History File (DHF), and Device History Record (DHR) are being eliminated, clarifying they are mapped to the Medical Device File (MDF), Design and Development File (DDP), and Batch or Lot Record respectively. She highlights three critical shifts: the explicit integration of lifecycle risk management as the 'DNA' of the QMS, the loss of audit privilege making internal records inspectable, and retained US-specific requirements like UDI in complaint records and extended record retention.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.